Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis

Clinical Rheumatology

Volumn 24, Issue 3, 2005, Pages 244-250

  Tikiz, Canan ^a,c   Ünlü, Zeliha ^a   Şener, Asli ^a   Efe, Murat ^b   Tüzün, Çigdem ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b SSK Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Efficacy; Hip osteoarthritis; Hylan G F 20; Low molecular hyaluronan; Outcomes

Indexed keywords

ANALGESIC AGENT; HIGH MOLECULAR WEIGHT HYALURONIC ACID; HYALURONIC ACID; HYLAN G F 20; LOW MOLECULAR WEIGHT HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OSTENIL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FLUOROSCOPY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HIP OSTEOARTHRITIS; HUMAN; INFLAMMATION; MALE; PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; VISUAL ANALOG SCALE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 20944442302     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1013-5     Document Type: Article

References (32)

1. Thomas E, Wilkie R, Peat G, Hill S, Dziedzic K, Croft P (2004) The North Staffordshire Osteoarthritis Project - NorStOP: Prospective, 3-year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 5:2 10.1186/ 1471-2474-5-2
2. Ling SM, Bathon JM (1998) Osteoarthritis in older adults. J Am Geriatr Soc 46:216-225
3. Pelletier JP, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 20:19-23
4. Kirvan J (2001) Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 8:93-101 1:STN:280:DC%2BD3MnltlOrsg%3D%3D
5. Balazs EA, Denlinger JL (1993) Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 20:3-9
6. Frizziero L, Govoni E, Bachin P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: Clinical and morphological study. Clin Exp Rheumatol 16:441-449
7. Altman RD, Moskowitz R (1998) Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 25:2203-2212
8. Tasciotaoglu F, Oner C (2003) Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 22:112-117
9. Neustadt DH (2003) Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 21:307-311
10. Maheu E, Ayral X, Dougados M (2002) A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: A review of clinical trials with Hyalgan. Int J Clin Pract 56:804-813
11. Balazs EA, Leshchiner A (1992) Biomatrix, Inc., assigne. Hylan preparation and method of recovery there of from animal tissues. US Patent 5, 099, 013 24 March 1992
12. EA Balazs EA Leshchiner 1989 Hyaluronan, its cross-linked derivate-hylan-and their medical applications In: H Inagaki GO Phillips (Eds.) Cellulosics utilization: Research and rewards in cellulosics. Proceedings of Nisshinbo International Conference on Cellulosics Utilization in the Near Future Elsevier Applied Science New York pp 233-241
13. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: A comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21:1549-1562 1:CAS:528:DyaK1MXms12iurs%3D
14. Vad VB, Sakalkale D, Sculco TP, Thomas L (2003) Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84:1224-1226 10.1016/S0003-9993(03)00140-0
15. Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L (2002) Hip osteoarthritis: Short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69:388-391 12184436
16. Caglar-Yagci H, Unsal S, Yagci I, Dulgeroglu D, Ozel S (2004) Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 in osteoarthritis of the hip: A pilot study. Rheumatol Int DOI: 10.1007/ s00296-004-0441-5
17. Conrozier T, Bertin B, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic osteoarthritis: An open-label, multicentre, pilot study. Clin Exp Rheumatol 21:605-610 1:STN:280:DC%2BD3srjtlWjsA%3D%3D
18. Bayramoglu M, Karatas M, Çetin N, Akman N, Sözay S, Dilek A (2003) Comparison of two different viscosupplements in knee osteoarthritis - a pilot study. Clin Rheumatol 22:118-122
19. Karlsson J, Sjögren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41:1240-1248
20. Altman R, Alarcon G, Appelrouth D (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-514 1:STN:280:By6B383islY%3D
21. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:495-501
22. Price DD, Hawkins SW (1987) Combined use of experimental pain and visual analog scales in providing standardized measurements of clinical pain. Clin J Pain 3:1-8
23. Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation - value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85-89 1:STN:280:BieD2s%2Fks1A%3D
24. Nicholas Bellamy, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes of anti-rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840 1:STN:280:BiaC2MjkvVc%3D
25. Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritic: Are the effects molecular weight dependent? Semin Arthritis Rheum 32:10-37 10.1053/ sarh.2002.33720
26. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20:410-423 10.1016/S0149-2918(98)80052-0
27. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT (2001) Efficacy and safety of intra-articular sodium hyaluronate in knee osteoarthritis. Clin Orthop 385:130-143 11302304
28. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo-controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55:424-431
29. Migliore A, Martin LSM, Alimonti A, Valente C, Tormenta S (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305-306 1:STN:280:DC%2BD3s7msFWmtQ%3D%3D
30. Bernard TN, Kirkaldis-Waldis WH (1987) Recognizing specific characteristics of nonspecific low back pain. Clin Orthop 217:226-280
31. Namik O, Toyosima H, Morisaki N (1982) Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid in osteoarthritis of the knee. J Clin Pharm Ther Toxicol 20:501-507
32. Chevalier X, Conrozier T, Bertin P, Bailleul F, Vignon E (2000) Treatment of patients with symptomatic hip OA. A pilot study with intra-articular hylan G-F 20 (Synvisc). Arthritis Rheum 43 [Suppl]:384